Clinical Trial: A Clinical Study Evaluating the Safety, Tolerability, Biodistribution, Radiation Dosimetry and Preliminary Diagnostic Performance of 68Ga-TPP-PSMA in Patients with Prostate Cancer (China)

Posted On: 2026-08-14

China, Aug. 14 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Clinical Study Evaluating the Safety, Tolerability, Biodistribution, Radiation Dosimetry and Preliminary Diagnostic Performance of 68Ga-TPP-PSMA in Patients with Prostate Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130055

Registration Time: 2026/08/13

Type: Interventional study

Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333717

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A Clinical Study Evaluating the Safety, Tolerability, Biodistribution, Radiation Dosimetry and Preliminary Diagnostic Performance of 68Ga-TPP-PSMA in Patients with Prostate Cancer (China)